Xem mẫu
- Tæ
Tæ leä nöõ tham gia trong caùc nghieân cöùu
phoøng ngöøa tieân phaùt baèng statin
ti
WOSCOPS: 0
WOSCOPS:
AFCAPS/TexCAPS:
AFCAPS/TexCAPS: 15% (997 /6605)
JUPITER
JUPITER : 38,2% (6801 /17.802)
- JUPITER – Women Subgroup Data
Rosuvastatin Placebo
N (Rate*) N (Rate*) HR (95% CI) P-value
Women N=3426 N=3375
Primary endpoint** 39 (0.56) 70 (1.04) 0.54 (0.37-0.80) 0.002
Any MI 10 (0.14) 18 (0.27) 0.54 (0.25-1.18) 0.11
Any stroke 18 (0.26) 23 (0.34) 0.77 (0.42-1.42) 0.40
Arterial revascularisation 8 (0.12) 29 (0.43) 0.27 (0.12-0.59) 0.0003
Arterial revascularisation or 8 (0.12)
(0 33 (0.49)
(0 0.24 (0.11-0.51)
(0
- Nguy
Nguy cô tim maïch ôû ngöôøi beänh thaän maïn
(Harper CR. J Am Coll Cardiol 2008;51:2375-84)
nguon tai.lieu . vn